The structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitors (Q74086226)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

The structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Peter Sondermann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Vaughan Oosthuizen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

51-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

The IgG Fc receptor family

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Soluble Fc gamma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Crystallographic structure studies of an IgG molecule and an Fc fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Crystal structure of the complex of rat neonatal Fc receptor with Fc

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Crystal structure of the soluble form of the human fcgamma-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Convergent solutions to binding at a protein-protein interface

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Structural basis of the interaction between IgG and fcγ receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Crystal structure of the extracellular domain of a human Fc gamma RIII

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Molecular basis for immune complex recognition: a comparison of Fc-receptor structures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Specific versus non-specific contacts in protein crystals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Characterization and crystallization of soluble human Fc gamma receptor II (CD32) isoforms produced in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Human Fcgamma receptor IIb expressed in Escherichia coli reveals IgG binding capability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Covalent structure of a human γG-immunoglobulin. VIII. Amino acid sequence of heavy-chain cyanogen bromide fragments H5-H7

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Peptide Inhibition of the Prausnitz-Küstner Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Application of synthetic peptides representative of immunoglobulin sequences to the delineation of receptor binding and signalling processes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

The use of synthetic γ-chain peptides in the localization of the binding site(s) on human IgG1 for the Fc receptors of homologous monocytes and heterologous mouse macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Localization of the IgG effector site for monocyte receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

A novel family of hairpin peptides that inhibit IgE activity by binding to the high-affinity IgE receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Solid-phase synthesis and cyclization of a large branched peptide from IgG Fc with affinity for Fc gammaRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

The structure of the IgE Cepsilon2 domain and its role in stabilizing the complex with its high-affinity receptor FcepsilonRIalpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Clinical experience with CD64-directed immunotherapy. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

Omalizumab, a novel anti-IgE therapy in allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900018-4

7 January 2021

10.1016/S0165-2478(02)00018-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12008034%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference